---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-208059"
form_type: "8-K"
ticker: "VERU"
cik: "0000863894"
company_name: "VERU INC."
filed_at: "2023-08-10T23:59:59+00:00"
generated_at: "2026-06-11T20:55:03.929933+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Veru Q3 net income $6.3M on ENTADFI gain; pipeline updates for enobosarm, sabizabulin

## Summary
- Net income $6.3M ($0.07/diluted share) vs net loss $22.2M ($0.28) in Q3 2022; revenue $3.3M down from $9.6M.
- Cash burn reduced to $7.3M in Q3, down $16.1M from prior quarter; cash $16.2M at June 30, 2023.
- Sold ENTADFI for $20M in April 2023; potential $80M in sales milestones. Gain of $17.5M recognized.
- FDA agrees on Phase 3 ENABLAR-2 design; ORR endpoint in Stage 1 may support accelerated approval for enobosarm in metastatic breast cancer.
- Plans to expand sabizabulin Phase 3 confirmatory study to all viral lung infections; FDA meeting scheduled for September 2023.

## SEC filing metadata
- accession: 0001193125-23-208059
- form_type: 8-K
- ticker: VERU
- cik: 0000863894
- company_name: VERU INC.
- filed_at: 2023-08-10T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/863894/000119312523208059/0001193125-23-208059-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/863894/000119312523208059/d463183d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-208059
- JSON: https://secwatch.observer/filing/0001193125-23-208059.json
- Plain text: https://secwatch.observer/filing/0001193125-23-208059.txt

## Key facts
- Earnings Releases
  VERU INC. reported financial results for the quarter and nine months ended June 30, 2023.
  - Period: the quarter and nine months ended June 30, 2023
  - Result: reported results
  source text: On August 10, 2023, Veru Inc. issued a press release (the “Press Release”) announcing results for the quarter and nine months ended June 30, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/863894/000119312523208059/0001193125-23-208059-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.